AUG 07, 2019 11:18 AM PDT

Chemotherapeutics react differently to radiation

WRITTEN BY: Nouran Amin

Patients with various types of cancer are almost always treated with a combination of chemotherapy and radiotherapy. In chemotherapy, therapeutics consist of drugs that inhibit cancer cells from reproducing—however, the side-effects can be cumbersome as the medication often affects the entire body. For radiotherapy, patients undergo targeted radiation to kill the cancer cells at the tumor site.

Now, in a recent study published in the journal EPJ D, scientists from the Leopold-Franzens-University Innsbruck, in Innsbruck, Austria, have examined marker molecules relevant to the context of chemo and radiotherapy. Specifically, researchers wanted to see if these molecules were individually affected by radiation similar to that used in radiotherapy.

Findings showed that particular molecules used in the common chemotherapy drugs are known for being radiosensitisers--these molecules may increase rate of DNA damage in tumor cells. Other chemotherapeutic molecules will prevent the DNA of tumor cells from repairing itself or duplicating. One process involves ionization—which is critical in radiation and the molecules of interest. Ionization involves a radiation particle colliding with a molecule where subsequently an electron is expelled from the molecule.

The presence of water in biological matter was not a striking finding in the study as this is usually the case. However, water does affect ionization process which implicates many studies that involve experiments consisting of stimulating radiation damages that are conducted in the gas phase.

“However, to describe this process in a more realistic setting, the aqueous environment needs to be taken into account,” stated co-author, Stefan Huber

Study authors are hopeful that their findings can eventually improve the way radiation is utilized for cancer treatment.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 19, 2019
Microbiology
SEP 19, 2019
Vulnerability in Famously Hard-to-Target Viruses is Identified
The cold virus is famously difficult to target with drugs because it can mutate rapidly....
SEP 19, 2019
Drug Discovery & Development
SEP 19, 2019
The Composition of Cerebrospinal Fluid in MS patients Could Be The Key To Treatments That Halt Progression
The range of disability for individuals living with multiple sclerosis (MS) varies significantly depending on the relapsing/remitting form of the disease....
SEP 19, 2019
Health & Medicine
SEP 19, 2019
Ketamine is not an opioid, and treats depression in a novel way
In March, the U.S. Food and Drug Administration approved ketamine nasal spray to treat depression. Ketamine has gotten a bad rep as an opioid - which it is...
SEP 19, 2019
Drug Discovery & Development
SEP 19, 2019
Novel Therapy Shows Promise for Acute Migraines
In a study published in The New England Journal of Medicine, a novel drug, by the name of rimegepant, was found to eliminate pain and reduce characteristic...
SEP 19, 2019
Drug Discovery & Development
SEP 19, 2019
Insulin Drug Could Treat Glioblastoma
A molecule used for drug delivery of insulin was recently found by researchers at the University of Georgia’s Regenerative Bioscience Center to hold...
SEP 19, 2019
Drug Discovery & Development
SEP 19, 2019
Does TruBrain Really Work?
TruBrain is a mix of different substances claimed to help people increase verbal fluency, avoid distractions, and boost their mental output. Created by a t...
Loading Comments...